{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:12:01Z","timestamp":1792023121194,"version":"4.4.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health Service"},{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004856","name":"Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Network"},{"name":"National Institute for Health Research Clinician Scientist"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The\u00a0AsseSSing Impact in pSoriatic Treatment (ASSIST) study investigated prescribing in routine PsA care and whether the patient-reported outcome\u2014PsA Impact of Disease questionnaire (PsAID-12)\u2014impacted treatment. This study also assessed a range of patient and clinician factors and their relationship to PsAID-12 scoring and treatment modification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with PsA were selected across the UK and Europe between July 2021 and March 2022. Patients completed the PsAID questionnaire and the results were shared with their physician. Patient characteristics, disease activity, current treatment methods, treatment strategies, medication changes and patient satisfaction scores were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 503 patients were recruited. Some 36.2% had changes made to treatment, and 88.8% of these had treatment escalation. Overall, the mean PsAID-12 score was higher for patients with treatment escalation; increase in PSAID-12 score is associated with increased odds of treatment escalation (odds ratio 1.58; P\u2009&amp;lt;\u20090.0001). However, most clinicians reported that PsAID-12 did not impact their decision to escalate treatment, instead supporting treatment reduction decisions. Physician\u2019s assessment of disease activity had the most statistically significant effect on likelihood of treatment escalation (odds ratio 2.68, per 1-point score increase). Escalation was more likely in patients not treated with biologic therapies. Additional factors associated with treatment escalation included: patient characteristics, physician characteristics, disease activity and disease impact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlights multiple factors impacting treatment decision-making for individuals with PsA. PsAID-12 scoring correlates with multiple measures of disease severity and odds of treatment escalation. However, most clinicians reported that the PsAID-12 did not influence treatment escalation decisions. Psoriatic Arthritis Impact of Disease (PsAID) scoring could be used to increase confidence in treatment de-escalation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead679","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:24:47Z","timestamp":1704673487000},"page":"242-251","source":"Crossref","is-referenced-by-count":10,"title":["How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1795-0099","authenticated-orcid":false,"given":"Conor","family":"Coyle","sequence":"first","affiliation":[{"name":"Oxford University, John Radcliffe Hospital, Oxford University Hospitals , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2005-2708","authenticated-orcid":false,"given":"Lily","family":"Watson","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, University of Bristol , Bristol,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Whately-Smith","sequence":"additional","affiliation":[{"name":"Consultant Biostatistician, Whately-Smith Ltd , Herts,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mel","family":"Brooke","sequence":"additional","affiliation":[{"name":"Royal National Hospital for Rheumatic Diseases, Royal United Hospitals , Bath,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5668-4497","authenticated-orcid":false,"given":"Uta","family":"Kiltz","sequence":"additional","affiliation":[{"name":"Ruhr-Universit\u00e4t Bochum, and Rheumazentrum Ruhrgebiet , Bochum,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-5328","authenticated-orcid":false,"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[{"name":"Academic Rheumatology Unit, Department of Medicine and Health Sciences \u201cVincenzo Tiberio\u201d, University of Molise , Campobasso,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8418-7145","authenticated-orcid":false,"given":"Ruben","family":"Queiro","sequence":"additional","affiliation":[{"name":"Rheumatology & ISPA Translational Immunology Division, Faculty of Medicine, Rheumatology Service & the Principality of Asturias Institute for Health Research (ISPA), Universidad de Oviedo , Oviedo,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Trigos","sequence":"additional","affiliation":[{"name":"Acci\u00f3n Psoriasis , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Brandt-Juergens","sequence":"additional","affiliation":[{"name":"Rheumatologische Schwerpunktpraxis , Berlin,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4459-8609","authenticated-orcid":false,"given":"Ernest","family":"Choy","sequence":"additional","affiliation":[{"name":"CREATE Centre, Division of Infection and Immunity, Cardiff University , Cardiff,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"D\u2019Angelo","sequence":"additional","affiliation":[{"name":"Rheumatology Department of Lucania, San Carlo Hospital , Potenza,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Delle Sedie","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Dernis","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Centre Hospitalier du Mans , Le Mans,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9o","family":"Wirth","sequence":"additional","affiliation":[{"name":"Rheumatology Department, INSERM UMRs1097 Autoimmune Arthritis, Aix Marseille University , Marseille,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Guis","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Aix Marseille University, Arthrites Autoimmunes , Marseille,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4155-9105","authenticated-orcid":false,"given":"Philip","family":"Helliwell","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Ho","sequence":"additional","affiliation":[{"name":"The Kellgren Centre for Rheumatology, Manchester University NHS Foundation Trust , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Hueber","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Klinikum N\u00fcrnberg, Paracelsus Medical University , N\u00fcrnberg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Joven","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Universitario 12 Octubre , Madrid,","place":["Spain"]},{"name":"Universidad Complutense de Madrid, Avda de C\u00f3rdoba sin , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Koehm","sequence":"additional","affiliation":[{"name":"Rheumatology, Universitiy Hospital Frankfurt, Fraunhofer-Institute for Translational Medicine and Cluster of Excellence Immune-Mediated Diseases CIMD , Frankfurt am Main,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Montilla","family":"Morales","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Universitario Salamanca , Salamanca,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Packham","sequence":"additional","affiliation":[{"name":"Academic Unit of Population and Lifespan Sciences, University of Nottingham , Nottingham,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio","family":"Pinto Tasende","sequence":"additional","affiliation":[{"name":"Rheumatology Department, INIBIC. CHU A Coru\u00f1a , A Coru\u00f1a,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Arthritis Unit, Rheumatology Department, Hospital Clinic , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Ruyssen-Witrand","sequence":"additional","affiliation":[{"name":"Rheumatology Center, Toulouse University Hospital, CIC 1436 Inserm, Rheumatology , Tolouse,","place":["France"]},{"name":"Paul Sabatier University, Toulouse III , Toulouse,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2889-8962","authenticated-orcid":false,"given":"Rossana","family":"Scrivo","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Twigg","sequence":"additional","affiliation":[{"name":"Rheumatology, Bradford Teaching Hospitals NHS Foundation Trust , Bradford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Welcker","sequence":"additional","affiliation":[{"name":"MVZ f\u00fcr Rheumatologie Dr M. Welcker GmbH , Planegg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9349-0720","authenticated-orcid":false,"given":"Martin","family":"Soubrier","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Gabriel-Montpied Teaching Hospital of Clermont-Ferrand , Clermont-Ferrand,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Gossec","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, Paris, FR. & AP-HP, Piti\u00e9-Salp\u00eatri\u00e8re Hospital , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4756-663X","authenticated-orcid":false,"given":"Laura C","family":"Coates","sequence":"additional","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"2025010608394638000_kead679-B1","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"New Engl J Med"},{"key":"2025010608394638000_kead679-B2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 [published correction appears in Nat Rev Rheumatol. 2022. Dec;18(12):734]","volume":"18","author":"Coates","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2025010608394638000_kead679-B3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025010608394638000_kead679-B4","doi-asserted-by":"crossref","first-page":"xv","DOI":"10.1016\/j.rdc.2016.02.001","article-title":"The Patient Experience: patient-Reported Outcomes in Rheumatology","volume":"42","author":"Barton","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"2025010608394638000_kead679-B5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","article-title":"A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative","volume":"73","author":"Gossec","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2025010608394638000_kead679-B6","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3899\/jrheum.181077","article-title":"PsAID12 provisionally endorsed at OMERACT 2018 as core outcome measure to assess psoriatic arthritis-specific health-related quality of life in clinical trials","volume":"46","author":"Orbai","year":"2019","journal-title":"J Rheumatol"},{"key":"2025010608394638000_kead679-B7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3899\/jrheum.160116","article-title":"Report of the GRAPPA-OMERACT psoriatic arthritis working group from the GRAPPA 2015 annual meeting","volume":"43","author":"Orbai","year":"2016","journal-title":"J Rheumatol"},{"key":"2025010608394638000_kead679-B8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.160924","article-title":"The 12-item psoriatic arthritis impact of disease questionnaire: construct validity, reliability, and interpretability in a clinical setting","volume":"44","author":"Di Carlo","year":"2017","journal-title":"J Rheumatol"},{"key":"2025010608394638000_kead679-B9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s42358-020-00149-1","article-title":"Validation and clinical interpretability of PsAID\u2014psoriatic arthritis impact of disease","volume":"60","author":"Da Cruz Ribeiro E Souza","year":"2020","journal-title":"Adv Rheumatol"},{"key":"2025010608394638000_kead679-B10","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3899\/jrheum.191056","article-title":"Expert consensus on a set of outcomes to assess the effectiveness of biologic treatment in psoriatic arthritis: the MERECES Study","volume":"47","author":"Ca\u00f1ete","year":"2020","journal-title":"J Rheumatol"},{"key":"2025010608394638000_kead679-B11","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2025010608394638000_kead679-B12","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/annrheumdis-2012-201341","article-title":"The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)","volume":"72","author":"Helliwell","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025010608394638000_kead679-B13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jclinepi.2004.10.018","article-title":"The development of a comorbidity index with physical function as the outcome","volume":"58","author":"Groll","year":"2005","journal-title":"J Clin Epidemiol"},{"issue":"Suppl 11","key":"2025010608394638000_kead679-B14","first-page":"S64","article-title":"Measures of psoriatic arthritis: tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander\/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI)","volume":"63","author":"Mease","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025010608394638000_kead679-B15","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.2196\/jmir.3085","article-title":"The psychometric properties of CollaboRATE: a fast and frugal patient-reported measure of the shared decision-making process","volume":"16","author":"Barr","year":"2014","journal-title":"J Med Internet Res"},{"key":"2025010608394638000_kead679-B16","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"2025010608394638000_kead679-B17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pec.2013.05.009","article-title":"Developing CollaboRATE: a fast and frugal patient-reported measure of shared decision making in clinical encounters","volume":"93","author":"Elwyn","year":"2013","journal-title":"Patient Educ Couns"},{"key":"2025010608394638000_kead679-B18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1532-5415.1998.tb02725.x","article-title":"Perceived Efficacy in Patient-Physician Interactions (PEPPI): validation of an instrument in older persons","volume":"46","author":"Maly","year":"1998","journal-title":"J Am Geriatr Soc"},{"key":"2025010608394638000_kead679-B19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pec.2011.07.017","article-title":"Further validation of the 5-item Perceived Efficacy in Patient-Physician Interactions (PEPPI-5) scale in patients with osteoarthritis","volume":"87","author":"ten Klooster","year":"2012","journal-title":"Patient Educ Couns"},{"key":"2025010608394638000_kead679-B20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7861\/clinmedicine.17-1-65","article-title":"Psoriatic arthritis: state of the art review","volume":"17","author":"Coates","year":"2017","journal-title":"Clin Med (Lond)"},{"key":"2025010608394638000_kead679-B21","volume-title":"SAS\/ACCESS\u00ae 9.4 interface to ADABAS: reference","author":"SAS Institute Inc","year":"2013"},{"key":"2025010608394638000_kead679-B22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13075-022-02838-2","article-title":"Minimal disease activity (MDA) in patients with recentonset psoriatic arthritis: predictive model based on machine learning","volume":"24","author":"Queiro","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2025010608394638000_kead679-B23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/rheumatology\/kes285","article-title":"Relative importance of doctorreported outcomes vs patient-reported outcomes in DMARD intensification for rheumatoid arthritis: the DUO study","volume":"52","author":"Dougados","year":"2013","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead679\/56427878\/kead679.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/1\/242\/56427878\/kead679.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/1\/242\/56427878\/kead679.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T03:41:15Z","timestamp":1736134875000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/1\/242\/7513167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,8]]},"published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead679","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,1,8]]}}}